Kader Karli Oguz

Kader Karli Oguz

Auto-generated profile, based on publicly available information

Kader Karli Oguz

Department of Radiology, Division of Neuroradiology UC Davis Medical Center Sacramento California USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Medical Image Analysis
Verified
Journal Article
Closed access
ODOnat Dalmaz
Onat Dalmaz
MMMuhammad U. Mirza
Muhammad U. Mirza
GEGokberk Elmas
Gokberk Elmas
MOMuzaffer Ozbey
Muzaffer Ozbey
SDSalman U.H. Dar
Salman U.H. Dar
TÇTolga Çukur
Tolga Çukur

26 March 2022 in Medical Image Analysis
Verified
Journal Article
Closed access
MYMahmut Yurt
Mahmut Yurt
MÖMuzaffer Özbey
Muzaffer Özbey
SDSalman U.H. Dar
Salman U.H. Dar
BTBerk Tinaz
Berk Tinaz
KOKader K. Oguz
Kader K. Oguz
TÇTolga Çukur
Tolga Çukur

22 May 2019 in Human Genome Variation
Verified
Journal Article
Open access
PDF file
RSRosanne Sprute
Rosanne Sprute
DADidem Ardicli
Didem Ardicli
KOKader Karli Oguz
Kader Karli Oguz
AMAnna Malenica-Mandel
Anna Malenica-Mandel
HDHülya-Sevcan Daimagüler
Hülya-Sevcan Daimagüler
SCSebahattin Cirak
Sebahattin Cirak
Asparagine synthetase deficiency (ASNSD, OMIM #615574) is a rare autosomal recessive neurometabolic inborn error that leads to severe cognitive impairment. It manifests with microcephaly, intractable seizures, and progressive cerebral atrophy. Currently, there is no established treatment for this condition. In our pediatric cohort, we discovered, by whole-exome sequencing in two siblings from Turkey, a novel homozygous missense mutation in asparagine synthetase at NM_133436.3 (ASNS_v001): c.1108C>T that results in an amino acid exchange p.(Leu370Phe), in the C-terminal domain. After identification of the metabolic defect, treatment with oral asparagine supplementation was attempted in both patients for 24 months. Asparagine supplementation was well tolerated, and no further disease progression was observed during treatment. One of our patients showed mild developmental progress with increased levels of attention and improved nonverbal communication. These results support our hypothesis that asparagine supplementation should be further investigated as a treatment option for ASNSD. We further reviewed all previously reported ASNSD cases with regard for their clinical phenotypes and brain imaging findings to provide an essential knowledge base for rapid diagnosis and future clinical studies.

1 February 2020 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
EBErtugrul Cagri Bolek
Ertugrul Cagri Bolek
ASAlper Sari
Alper Sari
LKLevent Kilic
Levent Kilic
UKUmut Klayoncu
Umut Klayoncu
AKAsli Kurne
Asli Kurne
OKOmer Karadag
Omer Karadag

1 June 2007 in Brain and Development
Verified
Journal Article
Closed access
KOKader Karlı Oguz
Kader Karlı Oguz
ACAsli Celebi
Asli Celebi
BABanu Anlar
Banu Anlar

24 September 2020 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
TATekin Aksu
Tekin Aksu
FGFatma Gümrük
Fatma Gümrük
TBTuran Bayhan
Turan Bayhan
ÇCÇağrı Coşkun
Çağrı Coşkun
KOKader K. Oğuz
Kader K. Oğuz
SUSule Unal
Sule Unal